| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/15/1992 | US5147865 Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses |
| 09/15/1992 | US5147862 Administering a 1,3-glucan |
| 09/15/1992 | US5147860 Tan-1120, its derivatives, production and use thereof |
| 09/15/1992 | US5147859 Complexes of glycerrhetinic acid with phospholipids and pharmaceutical and cosmetic compositions containing them |
| 09/15/1992 | US5147858 Acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant |
| 09/15/1992 | US5147857 Glycolic acid derivatives |
| 09/15/1992 | US5147854 Tgf-b compositions and method |
| 09/15/1992 | US5147664 Process for preparing an aqueous solution of an alkali metal salt of methionine |
| 09/15/1992 | US5147654 Stop smoking |
| 09/15/1992 | US5147652 Alpha ketoaldehydes |
| 09/15/1992 | US5147648 Method of improving the adhesiveness of gels to mucosae |
| 09/15/1992 | US5147294 Therapeutic method for reducing chronic pain in a living subject |
| 09/15/1992 | US5147291 Sound transmission gel; antiinflammatory agent |
| 09/15/1992 | CA2106097A1 Cosmetic or pharmaceutical, especially dermatological, composition, containing oxyacanthine, in particular for stimulating hair growth or retarding hair loss |
| 09/15/1992 | CA2101335A1 Reissert compounds as anti-hiv agents |
| 09/15/1992 | CA1307537C N-naphthoylglycines as aldose reductase inhibitors |
| 09/15/1992 | CA1307532C Azachromane derivates |
| 09/15/1992 | CA1307530C Carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments |
| 09/15/1992 | CA1307529C Aminoacyllabdanes, a process and intermediates for their preparation and their use as medicaments |
| 09/15/1992 | CA1307526C Bcd tricyclic ergoline part-structure analogues |
| 09/15/1992 | CA1307525C Sulfoamino derivatives of chondroitin sulfates, of dermatan sulfate and hyaluronic acid and their pharmacological properties |
| 09/15/1992 | CA1307524C Dispersions of chitin and product therefrom |
| 09/15/1992 | CA1307523C Platium compounds suitable for use as pharmaceuticals |
| 09/15/1992 | CA1307522C Pregnane derivatives, processes for their preparation and pharmaceuticalcompositions containing same |
| 09/15/1992 | CA1307467C Composition for the treatment of acne and seborrhea an hydroperoxide as active ingredient |
| 09/15/1992 | CA1307466C Inhibition of protein kinase c by long-chain bases |
| 09/15/1992 | CA1307465C Sucralfate preparations for application on esophagus mucosa |
| 09/15/1992 | CA1307464C Lyophilized or precipitated cephalosporin zwitterion and salt composition |
| 09/14/1992 | WO1992016526A1 Thiazole derivatives |
| 09/14/1992 | WO1992016276A1 PROCESS FOR PURIFICATION OF HMG-CoA REDUCTASE INHIBITORS |
| 09/14/1992 | CA2105981A1 Thiazole derivatives |
| 09/14/1992 | CA2104232A1 Process for purification of hmg-coa reductase inhibitors |
| 09/14/1992 | CA2062920A1 Compositions containing a special combination of carbohydrates to be utilized in dietetics and therapeutics, and their applications |
| 09/14/1992 | CA2062652A1 Gylcyrrhetic acid derivatives |
| 09/14/1992 | CA2061370A1 Pharmaceutical preparations |
| 09/14/1992 | CA2038781A1 Radiopharmaceutical agents for the detection of alzheimers disease |
| 09/13/1992 | WO1992016530A1 Cyclic ketal derivatives |
| 09/13/1992 | WO1992016504A1 New leukotriene b4 derivatives, method for preparing them and their use as drugs |
| 09/13/1992 | CA2106072A1 Cyclic ketal derivatives |
| 09/13/1992 | CA2082818A1 Leukotriene b4 derivatives, method for preparing them and their use as drugs |
| 09/13/1992 | CA2062655A1 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/12/1992 | WO1992016612A2 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2105997A1 Method of inhibiting padgem-mediated interactions using an inhibitor comprising a 2,6 sialic acid component |
| 09/12/1992 | CA2062263A1 Quinone derivatives |
| 09/12/1992 | CA2058059A1 Single layer transdermal drug administration system |
| 09/10/1992 | CA2061759A1 Trans-pt (iv) complexes |
| 09/09/1992 | WO1992015579A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | WO1992015295A1 Compositions containing sumatriptan |
| 09/09/1992 | EP0502788A1 Trisubstituted triazines and pyrimidines, process for their preparation and pharmaceutical compositions containing them |
| 09/09/1992 | EP0502786A1 Process for the preparation of aryl(or heteroaryl)-piperazin-1-butyl-azole derivatives |
| 09/09/1992 | EP0502766A1 Dietary compositions based on phosphorylated lipids and their use to improve vision troubles |
| 09/09/1992 | EP0502765A1 New dietary compositions based on phosphorylated lipid complexes and their use in sleeping disorders |
| 09/09/1992 | EP0502725A2 Substituted fused pyrimidinones |
| 09/09/1992 | EP0502709A1 Gallium compounds |
| 09/09/1992 | EP0502690A2 Cyclopropane derivative |
| 09/09/1992 | EP0502668A1 Imidazoacridines and their antineoplastic use |
| 09/09/1992 | EP0502666A1 Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers |
| 09/09/1992 | EP0502661A2 Heteroanthracycline anti-tumor analogues |
| 09/09/1992 | EP0502594A1 Chelates, their metal complexes as well as their use in diagnosis and therapy |
| 09/09/1992 | EP0502575A1 Substituted 1-(2H)-isoquinolinones |
| 09/09/1992 | EP0502556A1 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of acid labile compounds |
| 09/09/1992 | EP0502554A2 Composition comprising an oxygen radical scavenger and a surfaceactive copolymer |
| 09/09/1992 | EP0502550A1 Colominic acid and partial hydrolysis products of colominic acid for the preparation of medicaments for the treatment of hepatitis, nephritis and arthritis |
| 09/09/1992 | EP0502536A1 Phenyl amidines derivatives useful as platelet aggregation inhibitors |
| 09/09/1992 | EP0502502A1 Topical composition containing ketoprofen lysinate |
| 09/09/1992 | EP0502498A1 Phenoxyalkanoic acid derivatives and process for preparation thereof |
| 09/09/1992 | EP0502470A2 Compounds for the treatment of inflammation and allergy |
| 09/09/1992 | EP0502468A1 Antibacterial condensed carbapenemes |
| 09/09/1992 | EP0502465A1 Esters of antibacterial condensed carbapenemederivatives |
| 09/09/1992 | EP0502464A1 Antibacterial condensed carbapenemes |
| 09/09/1992 | EP0502418A1 Use of levemopamil for the manufacture of a medicament for the treatment of alcohol abuse |
| 09/09/1992 | EP0502392A1 Process for the preparation of D-(+)-biotin and intermediates in this process |
| 09/09/1992 | EP0502357A1 Optically active and racemic hydrated diacetylesters of alpha-glycero-phosphoryl-choline |
| 09/09/1992 | EP0502314A1 Benzimidazol, medicaments containing them and process for their preparation |
| 09/09/1992 | EP0502117A1 Polymers with alkyl- or heteroalkyl-aryl backbone and pharmaceutical compositions incorporating same |
| 09/09/1992 | EP0502110A1 (hetero) 4-arylmethoxy phenyl diazole derivatives, method for preparing same, and their therapeutical applications. |
| 09/09/1992 | EP0502106A1 Substituted indole-, indene-, pyranoindole- and tetrahydrocarbazole- alkanoic acid derivatives as inhibitors of pla2 and lipoxygenase |
| 09/09/1992 | EP0502100A1 Reduced-protein subunit vaccine for swine dysentery |
| 09/09/1992 | EP0502075A1 Carboxyalkylcarbonyl aminoacid endopeptidase inhibitors |
| 09/09/1992 | EP0502020A1 NOVEL BENZO [b] PHENANTHROLINE-1,7 DERIVATIVES, AND THEIR PREPARATION AND THERAPEUTICAL APPLICATIONS. |
| 09/09/1992 | EP0502015A1 N-acyl-substituted azacyclic compounds, processes for their preparation, and their use as pharmaceuticals |
| 09/09/1992 | EP0502007A1 Arginine nicotinate for reducing blood cholesterol |
| 09/09/1992 | EP0305400B1 A composition having reduced nephrotoxicity comprising a fatty acid containing component and cyclosporine |
| 09/09/1992 | EP0292517B1 Improvements in or relating to the use of epidermal growth factor |
| 09/09/1992 | EP0227818B1 Antiglaucoma compositions |
| 09/09/1992 | EP0214281B1 Protein absorption enhancing agents |
| 09/09/1992 | CN1064278A 4-deoxy-4-epipodophyllotoxin derivatives or pharmaceutically acceptable salt thereof |
| 09/09/1992 | CN1064277A 5-(substituted amino)-1,2,4-triazolo (1,5-a) pyrimidine derivatives |
| 09/09/1992 | CN1064276A 1,2,4-triazolo (1,5-a) pyrimidine derivatives and process for preparation thereof |
| 09/09/1992 | CN1064275A Imidazopyridine paf/h1 antagonists |
| 09/09/1992 | CN1064273A Benzene derivatives having ngf production-promoting activity |
| 09/09/1992 | CN1064271A 2,4-diaminoquinazolines derivatives for enhancing antitumor activity |
| 09/09/1992 | CN1064269A 4-pyrimdinone derivatives, their preparation and their application in therapy |
| 09/09/1992 | CN1064268A Process for preparing pharmaceutical composition containing salt of quinoline |
| 09/09/1992 | CN1018152B Preparation of melanin inhibitor |
| 09/09/1992 | CA2105655A1 Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors |
| 09/09/1992 | CA2062465A1 Soap compounded with vitamin b1-containing garlic extract |
| 09/09/1992 | CA2062456A1 Acylamino-substituted hetrazepines |
| 09/09/1992 | CA2062437A1 Acyclamenophenol derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them |
| 09/09/1992 | CA2062407A1 Benzopirene derivatives, a process for the preparation thereof and the pharmaceutical compositions containing them |